About this trial
The goal of this prospective observational study is to learn about the current prevalence of obstructive sleep apnea-hypopnea syndrome in community population, patients with specific diseases and special population from China. The main question it aims to answer is: (1) What are the prevalence and clinical characteristics of OSA in the community population, the specific disease population and the special population respectively? (2) How about the application value of each OSA screening questionnaire for different populations?Participants will all complete a screening questionnaire, and some will be selected by random sampling to complete either a polysomnography (PSG) or a portable sleep monitor (PM).
Eligibility criteria
Qualifiers
Sign the informed consent form before participating in the study
Complete independent behaviour and cognitive abilities
Ability to answer the questionnaire completely and accurately
Disqualifiers
Incomplete answers to the scale
Patients with severe diseases and acute infections or those requiring long-term home oxygen therapy
Patients with severe mental and psychological disorders
Patients with severe organ failure
Trial design
Treatments tested in this trial
- patients with hypertension, diabetes, cardiovascular and cerebrovascular diseases, chronic obstructive pulmonary disease, asthma and other OSA related comorbidities.
Treatment groups
Sponsors and collaborators
Kang Wu
Lead sponsor
Guangzhou Institute of Respiratory Disease
Sponsor institution